Development of an integrated biofoundry business
First written in FY2024-Q1. 5 of 11 entries say "Advanced", first in FY2024. Latest entry: 2026-11-11.
0 other companies' latest entry also says "Cited as achieved".
- FY2027-H1AdvancedAnnual report
「The group opened JBX1, the first building of the Bioprocess Research Institute (JBX), a bio-manufacturing research center in Kobe, Hyogo Prefecture, equipped with the world's first foundational facility for gas-circulating fermentation.」
For the Integrated Biofoundry and biomanufacturing business, the first building of the R&D centre in Kobe was opened, marking progress to the stage of advancing R&D, scale-up, and commercialisation in an integrated manner. - FY2026AdvancedAnnual report
「The Group completed construction of the Bioprocess Research Institute on Port Island in Kobe in January 2026. At the institute, it is developing the world’s first gas-circulating fermentation process technology, using the Group’s handling technologies for safely managing gas that it has cultivated over many years.」
For the Integrated Biofoundry business, the R&D centre in Kobe was completed in January 2026, and the business progressed to the stage of developing the world’s first gas-circulating fermentation process. - FY2025-H1AdvancedAnnual report
「In August of this year, the company began construction of a new research and development center, the world's first facility for bio-manufacturing using gas fermentation, on Port Island in Kobe, with completion scheduled for the end of 2025.」
For the Integrated Biofoundry business, construction began in Kobe of the world’s first R&D centre for gas-fermentation biomanufacturing, with completion scheduled for the end of 2025. - FY2024AdvancedAnnual report
「In addition, to establish a research and development platform for CO2-based bio-manufacturing in the Port Island district of Kobe, the company purchased land and is preparing to construct a research building.」
The Integrated Biofoundry and biomanufacturing business progressed to the purchase of land in Kobe and preparations for constructing a research building. - FY2024-Q1First statedAnnual report
「In response to the expected expansion of the future market for biomanufacturing, the Company also worked to diversify its business model, including by jointly building an “Integrated Biofoundry®” business with バッカス・バイオイノベーション株式会社, providing an integrated offering from microorganism development and improvement through bioreactor scale-up and production-process development.」
For biomanufacturing, the establishment of a joint business covering the entire process from microorganism development through bioreactor scale-up and production-process development was newly disclosed.